Metastatic malignant proliferating trichilemmal tumor detected by positron emission tomography

Dermatologic Surgery

Volumn 29, Issue 8, 2003, Pages 872-874

  Jung, Jeanne ^a   Cho, Sung Bin ^a   Yun, Mijin ^a   Lee, Kwang Hoon ^a   Chung, Kee Yang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; BOWEN DISEASE; CANCER RADIOTHERAPY; CASE REPORT; CAUTERIZATION; CHEMOSURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCALP TUMOR; TRICHILEMMOMA; TUMOR RECURRENCE;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; RADIOPHARMACEUTICALS; SCALP; SKIN NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0043166780     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29237.x     Document Type: Article

References (10)

1. Noto G, Pravatà G, Aricó M. Proliferating trichilemmal cyst should always be considered as a low-grade carcinoma. Dermatology 1997;194:374-5.
2. Noto G. Benign proliferating trichilemmal tumor: does it really exist. Histopathology 1999;35:386-90.
3. Noto G, Pravatà G, Aricó M. Malignant proliferating trichilemmal tumor. Am J Dermatopathol 1997;19:202-4.
4. Amaral AMP, Nascimento AG, Goellner JR. Proliferating pilar (trichilemmal) cyst: report of two cases, one with carcinomatous transformation and one with distant metastases. Arch Pathol Lab Med 1984;108:808-10.
5. Herrero J, Monteagudo C, Ruiz A, Llombart-Bosch A. Malignant proliferating trichilemmal tumors: an histopathological and immunohistochemical study of three cases with DNA ploidy and morphometric evaluation. Histopathology 1998;33:542-6.
6. Warburg O. The Metabolism of Tumors. New York: Richard R. Smith, 1931:129-69.
7. Pauwels EK, Sturm EJ, Bombardieri E, Cleton FJ, Stokkel MP. Positron-emission tomography with [18F]fluorodeoxyglucose: I: biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 2000;126:549-59.
8. Boni R, Boni RA, Steinert H, et al. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose. Br J Dermatol 1995;132:556-62.
9. Paul R. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for the detection of lymphoma. J Nucl Med 1987;28:288-92.
10. Brush J. Positron emission tomography in urological malignancy. Curr Opin Urol 2001;11:175-9.